Unidentified subject!
Rozanne Agricola <oqbvbycw@gilholm.com>
To: <apt@packages.debian.org>
Subject: Beat The Market Today,..TTTP...Hot Pick! nqnxtv
Date: Tue, 04 May 2004 07:08:18 -0500
MIME-Version: 1.0
X-Virus-Status: Scanned by norton
Content-Type: text/html; charset=us-ascii
Content-Transfer-Encoding: plain
<html><body>
<!--wmmtgc-->,.Hot Trading Alert..<!--koxvpb-->
<p> Get..OTCBB:_TTTP.OB,..Tue, 04 May 2004 06:56:46 -0500</p>
<p>Introduces VisionKare(TM) an Eye Specific Supplement<br>
for Macular Degeneration.873x78JE8a19wC1(58mw62a</p>
<p><strong><font color="#FF0000">TARGET PRICE IN NEXT 3-5 DAYS: $0.75 - 0.80<br>
TARGET PRICE IN NEXT 10 DAYS: $0.92 </font></strong></p>
<p>
<!--rsfuja-->
++ EXCITING NEWS JUST RELEASED FOR TTTP ++</p>
<p>Before we start with the profile of TTTP we would like to mention something
very important: <br>
THERE IS BIG PR CAMPAIGN STARTING on May 4th ITS EXPECTED THERE WILL BE HUGE
DEMAND FOR<br>
TTTP SHARES.</p>
<p>SO TAKE ADVANTAGE AND GET IN EARLY. THE TARGET PRICES BELOW ARE PRETTY MUCH
REALISTIC. </p>
<p>+>+>+>Company Profile +>+>+> </p>
<p><font color="#FF0000"><strong>Symbol: TTTP.OB</strong></font>
<!--mokaog-->
<br>
<strong><font color="#FF0000">Current Price: $0.16</font></strong><br>
<strong><font color="#FF0000">TARGET PRICE IN NEXT 3-5 DAYS: $0.75 - 0.80<br>
TARGET PRICE IN NEXT 10 DAYS: $0.92 </font></strong></p>
<p>How many times have you seen good stocks but you couldn't get your hands on
them in the right <br>
moment? We are alerting you to a special company with a unique product that
is set to be profiled <br>
by many newsletters in the next 5-10 days -- this is your chance to get in!</p>
<p>----------------------------------------------</p>
<p><font color="#FF0000"><strong>ABOUT THE COMPANY</strong></font></p>
<p>TTTP is an innovative company with a 21st century approach to the health issues
of today. Unlike traditional treatment regimens, TTTP’s approach focuses
on less harmful and more natural forms of therapies that yield effective results
while minimizing chemical dependence or harsh side effects. 12 to 20 Plus’
believes it has a successful prescription for growth—attracting, retaining
and successfully treating integrative health-conscious consumers. 12 to 20 Plus
has the products to fit the dynamics and trends of a global market. We Expect
some strong demand for this stock in the near future!!!!!</p>
<p>----------------------------------------------</p>
<p><font color="#FF0000"><strong>NEWS RELEASE</strong></font></p>
<p>SAN LUIS OBISPO, CA,, Apr. 30, 2004 (MARKET WIRE via COMTEX) -- (TTTP.OB) --
According to a recent poll, Americans dread blindness more than any other disability.
Recent studies indicate that by the year 2025, the population of people over
the age of 65 in the United States will be six times higher than in 1990. The
reason -- "baby boomers" are aging and overall life expectancy is
increasing. Since many people diagnosed with macular degeneration are over age
55, the number of cases of macular degeneration in the U.S. will increase significantly
as baby boomers age. </p>
<p>Said Carol Slavin, President "The market is very large, with about 50
million AMD sufferers worldwide (15 million in the U.S.) and five million new
cases each year. Less than 2% of all AMD cases are treated successfully, so
an urgent need exists for effective new strategies." We would anticipate
significant revenues in the millions of dollars as we increase our distribution
capabilities and our VisionKare(TM) brand becomes the "benchmark"
for the industry.</p>
<p>----------------------------------------------</p>
<p>*Forward-Looking...Statements-Disclaimer.,hcvvqr</p>
<p>Information within this email contains forward looking statements; within
the meaning of Section 27A of the Securities Act of 1933 and Section 21B of
the Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to <br>
predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions
or future events or performance are not statements of historical fact and may
be "forward looking statements." </p>
<p>Forward looking statements are based on expectations, estimates and projections
at the time the statements are made that involve a number of risks and uncertainties
which could cause actual results or events to differ materially from those presently
anticipated. Forward looking statements in this action may be identified through
the use of words such as: "projects", "foresee", "expects",
"estimates," "believes," "understands" "will,"
"part of: "anticipates," or that by statements indicating certain
actions "may," "could," or "might" occur. All
information provided within this email pertaining to investing, stocks, securities
must be understood as information provided and not investment advice. Emerging
Equity Alert advises all readers and subscribers to seek advice from a registered
professional securities representative before deciding to trade in stocks featured
within this email. None of the material within this report shall be construed
as any kind of investment advice. Please have in mind that the interpretation
<br>
of the witer of this newsletter about the news published by the company does
not represent the company official statement and in fact may differ from the
real meaning of what the news release meant to say. Please read the news release
by yourself and judge by yourself about the details in it.</p>
<p>ucmkbi eiuwea ncncsx kgdrkb cvrwae
dpkiah ejyrnm hmbrvg gibkgs iytmqg rnavyb
nqmufn </p>
</body>
</html>
Reply to: